Terug
46
Ook genoteerd als
ORINF
OTC
Dagbereik
€ 37,99
€ 40,52
52-Weeksbereik
€ 25,95
€ 42,75
Volume
7
50D / 200D Gem.
€ 39,70
/
€ 38,02
Vorige Slotkoers
€ 41,04
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 44,5 | 0,2 |
| P/B | 16,6 | 3,0 |
| ROE % | 42,0 | 3,6 |
| Net Margin % | 25,4 | 3,8 |
| Rev Growth 5Y % | 16,1 | 9,9 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
1,92B | 0 |
| FY2026 |
€ 2,30
€ 2,22 – € 2,38
|
2,22B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | N/A | € 1,08 | — |
| 2025-10-28 | N/A | € 0,40 | — |
| 2025-07-18 | N/A | € 0,33 | — |
| 2025-04-23 | N/A | € 0,23 | — |
| 2025-02-25 | N/A | € 0,28 | — |
| 2024-10-29 | N/A | € 0,63 | — |
| 2024-08-08 | N/A | € 0,17 | — |
| 2024-04-25 | N/A | € 0,17 | — |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,48%
Growth (3Y)
-9,50%
Growth (5Y)
-17,42%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 26, 2026 | Apr 17, 2026 | € 0,20 | 0,95% |
| Oct 16, 2025 | Nov 07, 2025 | € 0,17 | 1,58% |
| Apr 07, 2025 | Apr 29, 2025 | € 0,46 | 3,17% |
| Oct 16, 2024 | Nov 07, 2024 | € 0,44 | 3,32% |
| Mar 21, 2024 | Apr 18, 2024 | € 0,44 | 2,43% |
| Mar 23, 2023 | Apr 17, 2023 | € 0,87 | 3,31% |
| Mar 24, 2022 | Apr 18, 2022 | € 0,85 | 4,28% |
| Mar 26, 2021 | Apr 22, 2021 | € 0,89 | 4,34% |
| May 07, 2020 | Jun 01, 2020 | € 0,81 | 4,34% |
| Mar 26, 2020 | Apr 20, 2020 | € 0,83 | 4,47% |
| Mar 27, 2019 | Apr 19, 2019 | € 0,84 | 4,88% |
| Mar 21, 2018 | Apr 13, 2018 | € 0,89 | 5,60% |
| Mar 22, 2017 | Apr 17, 2017 | € 0,82 | 3,79% |
| Mar 22, 2016 | Apr 14, 2016 | € 0,74 | 4,38% |
Belangrijkste Punten
Revenue grew 16,07% annually over 5 years — strong growth
Earnings grew 45,67% over the past year
ROE of 41,98% indicates high profitability
Net margin of 25,43% shows strong profitability
Debt/Equity of 0,24 — conservative balance sheet
Generating 219,20M in free cash flow
Groei
Revenue Growth (5Y)
16,07%
Revenue (1Y)22,50%
Earnings (1Y)45,67%
FCF Growth (3Y)898,18%
Kwaliteit
Return on Equity
41,98%
ROIC29,80%
Net Margin25,43%
Op. Margin33,43%
Veiligheid
Debt / Equity
0,24
Current Ratio2,40
Interest Coverage75,58
Waardering
P/E Ratio
44,48
Forward P/E17,85
P/B Ratio16,64
EV/EBITDA34,07
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,50% | Revenue Growth (3Y) | 26,02% |
| Earnings Growth (1Y) | 45,67% | Earnings Growth (3Y) | 48,88% |
| Revenue Growth (5Y) | 16,07% | Earnings Growth (5Y) | 25,49% |
| Profitability | |||
| Revenue (TTM) | 1,89B | Net Income (TTM) | 480,55M |
| ROE | 41,98% | ROA | 23,91% |
| Gross Margin | 64,20% | Operating Margin | 33,43% |
| Net Margin | 25,43% | Free Cash Flow (TTM) | 219,20M |
| ROIC | 29,80% | FCF Growth (3Y) | 898,18% |
| Safety | |||
| Debt / Equity | 0,24 | Current Ratio | 2,40 |
| Interest Coverage | 75,58 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,48% |
| Dividend Growth (3Y) | -9,50% | Dividend Growth (5Y) | -17,42% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 44,48 | Forward P/E | 17,85 |
| P/B Ratio | 16,64 | P/S Ratio | 11,31 |
| PEG Ratio | -1,35 | Forward PEG | N/A |
| EV/EBITDA | 34,07 | Fwd EV/EBITDA | 30,29 |
| Forward P/S | 9,62 | Fwd Earnings Yield | 5,60% |
| FCF Yield | 1,03% | ||
| Market Cap | 21,37B | Enterprise Value | 21,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,89B | 1,54B | 1,19B | 1,34B | 1,04B |
| Net Income | 480,55M | 329,90M | 216,80M | 349,50M | 193,80M |
| EPS (Diluted) | 0,86 | 1,18 | 0,77 | 1,25 | 0,69 |
| Gross Profit | 1,21B | 946,40M | 657,80M | 849,00M | 593,50M |
| Operating Income | 631,60M | 416,60M | 274,90M | 439,60M | 243,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,01B | 1,63B | 1,44B | 1,50B | 1,11B |
| Total Liabilities | 725,40M | 624,10M | 548,50M | 595,50M | 366,10M |
| Shareholders' Equity | 1,28B | 1,01B | 890,10M | 908,10M | 747,90M |
| Total Debt | 305,27M | 327,30M | 200,10M | 214,00M | 108,50M |
| Cash & Equivalents | 160,90M | 205,60M | 106,70M | 332,60M | 216,70M |
| Current Assets | 1,34B | 1,02B | 825,30M | 878,60M | 690,20M |
| Current Liabilities | 560,30M | 273,40M | 264,80M | 275,50M | 209,20M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#105 of 158
Recente Activiteit
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026